Belgian IT Stock News

If you are weighing your next move with argenx stock, you are definitely not alone. After all, this is a company that has rewarded patience. Just looking at the numbers, argenx has surged 41.0% in the past year and an incredible 195.9% over five years. Even in the shorter term, the momentum is hard to ignore, with a 1.0% gain over the past week and a solid 4.5% for the month. With returns like these, it is no wonder there is so much buzz around what is driving the growth, how much upside...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

In late September 2025, Anheuser-Busch announced a US$7.4 million investment to upgrade brewing and packaging equipment at its Los Angeles brewery to boost Michelob ULTRA production in response to demand for new can sizes and formats as part of its wider “Brewing Futures” initiative, with over US$300 million earmarked for U.S. operations. This investment, along with a US$9 million expansion for Beyond Beer products in New York, highlights AB InBev’s focus on supporting manufacturing jobs,...

Colruyt Group (ENXTBR:COLR) has drawn attention from investors after recent market moves. The company’s latest performance offers a fresh angle to assess its valuation and prospects, especially given its returns this past year. See our latest analysis for Colruyt Group. Colruyt Group’s share price has slipped roughly 15% in the last month, reflecting shifting sentiment as broader market jitters set in. While some may focus on the recent slide, what stands out is the strong 57% total...

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...

UCB Pharma and Tanner Pharma Group recently announced a partnership aimed at enabling greater access to innovative treatments for epilepsy patients across Southeast Asia. This collaboration is significant as it may help UCB tap into new markets with high unmet medical needs, supporting their ambitions for global growth in specialty biopharma. With UCB expanding patient access through this new partnership, we’ll examine how such geographic growth could influence the company’s broader...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Readers hoping to buy Melexis NV ( EBR:MELE ) for its dividend will need to make their move shortly, as the stock is...

Fagron reported solid third quarter results, with 6.4% revenue growth and a confirmed full-year outlook, and announced Brazilian competition authority clearance for the acquisitions of Purifarma and Injeplast, advancing its M&A strategy in Latin America. The regulatory clearance and operational improvements, including completed corrective actions at the Wichita facility, position Fagron to expand its product range and enhance profitability across its global operations. We’ll examine how the...

In October 2025, Umicore announced it had sold its permanently tied up gold inventories from its Jewelry & Industrial Metals and Precious Metals Refining business units, generating €410 million in net proceeds and a significant after-tax capital gain of €370 million. This move enables Umicore to strengthen its balance sheet and optimize financing costs by shifting to revolving metal leases, increasing financial flexibility while maintaining operational effectiveness. Let's explore how...

DEME Group recently announced it has secured a sizable contract for the transport and installation of inter-array cables at the Nordseecluster B offshore wind farm in Germany, a joint project of RWE and Norges Bank Investment Management. This project strengthens DEME’s profile as a leading provider of offshore wind infrastructure services for major European energy partnerships. We'll examine how this significant contract win in German offshore wind could further reinforce DEME Group's global...

Melexis NV's ( EBR:MELE ) investors are due to receive a payment of €0.91 per share on 16th of October. This means the...

Umicore (ENXTBR:UMI) shares have drawn renewed investor interest lately, with quarterly results offering a clearer look at both recent profit trends and ongoing shifts in the materials sector. Investors are monitoring how performance metrics play into broader market sentiment. See our latest analysis for Umicore. Umicore’s share price has gained strong momentum lately, jumping over 59% year-to-date and up 20% in the last month alone. While the one-year total shareholder return stands at...

Anheuser-Busch InBev (ENXTBR:ABI) shares have shifted slightly this week, with investors watching recent performance and weighing the latest financial data. The beverage giant's stock remains a focus for those tracking consumer staples in Europe. See our latest analysis for Anheuser-Busch InBev. Anheuser-Busch InBev shares recently edged up, keeping the spotlight on the company's steady performance in a competitive landscape. Although the 1-day movement was muted, longer-term momentum paints...

The Viohalco S.A. ( EBR:VIO ) share price has done very well over the last month, posting an excellent gain of 25%. The...

If you own Colruyt Group stock, or are watching from the sidelines for the right entry point, you are not alone. The company’s recent performance has definitely raised a few eyebrows and stirred up some debate. Over the past year, Colruyt shares have shed 22.5%, continuing a downward trend that deepened with a 16.2% drop over the last 30 days alone. Year to date, the stock is off by 12.8%. That sounds rough, but if you zoom out a bit, you’ll see a three-year return of 53.6%, demonstrating...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Cenergy Holdings fair value estimate is €23.58 Current share...

If you are watching Proximus and wondering what to do next, you are not alone. With a share price that just closed at 7.3, investors have every reason to re-examine the stock’s direction. Over the last week, Proximus slipped by 0.9%, but that comes after a solid 1.0% climb in the last month and an impressive year-to-date surge of 43.3%. Looking back over the past year, the stock is up 17.0%, a stark contrast to where things stood five years ago with a drop of 37.4% over that period. What is...

Solvay (ENXTBR:SOLB) shares have seen some notable swings recently, prompting investors to revisit the company’s fundamentals. With a mixed performance over the past month and year, there is ongoing debate about Solvay’s current valuation. See our latest analysis for Solvay. After a notably uneven stretch over the past year, Solvay’s recent share price movement suggests momentum remains tepid, with investors appearing cautious as total shareholder return over one year dipped slightly into...

When close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Investor interest in NV Bekaert (ENXTBR:BEKB) has picked up ahead of the company’s presentation at this year's Baader Investment Conference in Munich. The upcoming event comes as the company experiences ongoing momentum, supported by multi-year share gains. See our latest analysis for NV Bekaert. Bekaert’s ongoing momentum comes after a period of steady, long-term value creation. Its 1-year total shareholder return sits at 14.5%, while the share price has held firm near €39. Recent moves like...

Argenx (ENXTBR:ARGX) has drawn fresh attention from investors after two key developments: a promising update on its ARGX-119 program for rare neuromuscular diseases and the deepening of a global manufacturing partnership with FUJIFILM Biotechnologies. See our latest analysis for argenx. argenx’s recent updates around clinical progress and supply chain expansion have helped fuel renewed optimism, even as momentum has remained measured. Its latest share price sits at $668.8, with a 1-year total...